ANO6 and hemorrhagic disease: Suzuki et al., (2010) first showed that TMEM16F is a Ca2+-activated phospholipid scramblase and that loss-of-function TMEM16F mutations cause the Scott syndrome, a human bleeding disorder caused by a defect in phospholipid scrambling [16,18].